Search Results - Xiaochen Zhao

Refine Results
  1. 1
    Comparison of Remimazolam and Propofol on Postoperative Delirium in Elderly Patients Undergoing Radical Resection of Colon Cancer: A Single-Center Prospective Randomized Controlled Study

    Comparison of Remimazolam and Propofol on Postoperative Delirium in Elderly Patients Undergoing Radical Resection of Colon Cancer: A Single-Center Prospective Randomized Controlled... by Tianlin Liu, Haochen Zhao, Xiaochen Zhao, Min Qu

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Isolation and Culture of Adult Mouse Cardiomyocytes for Cell Signaling and <em>in vitro</em> Cardiac Hypertrophy

    Isolation and Culture of Adult Mouse Cardiomyocytes for Cell Signaling and <em>in vitro</em> Cardiac Hypertrophy by Daxiang Li, Jian Wu, Yan Bai, Xiaochen Zhao, Lijun Liu

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Effects of Visual Perception of Building Materials on Human Emotional States and Cognitive Functioning in a Physical Learning Environment

    Effects of Visual Perception of Building Materials on Human Emotional States and Cognitive Functioning in a Physical Learning Environment by Yufeng Zhou, Xiaochen Zhao, Y. T. Feng, Changzheng Xuan, C. T. Yang, Xiaohu Jia

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    NaKtide, a Na/K-ATPase-derived Peptide Src Inhibitor, Antagonizes Ouabain-activated Signal Transduction in Cultured Cells

    NaKtide, a Na/K-ATPase-derived Peptide Src Inhibitor, Antagonizes Ouabain-activated Signal Transduction in Cultured Cells by Zhichuan Li, Ting Cai, Jiang Tian, Joe Xie, Xiaochen Zhao, Lijun Liu, Joseph I. Shapiro, Zijian Xie

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Distinct Inhibitory Circuits Orchestrate Cortical beta and gamma Band Oscillations

    Distinct Inhibitory Circuits Orchestrate Cortical beta and gamma Band Oscillations by Guang Chen, Yuan Zhang, Xiang Li, Xiaochen Zhao, Qian Ye, Yingxi Lin, Huizhong W. Tao, Malte J. Rasch, Xiaohui Zhang

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer

    Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer by Yuezong Bai, Tong Xie, Zhenghang Wang, Shuang Tong, Xiaochen Zhao, Feilong Zhao, Jinping Cai, Xiaofan Wei, Zhi Peng, Lin Shen

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    CNV Detection from Circulating Tumor DNA in Late Stage Non-Small Cell Lung Cancer Patients

    CNV Detection from Circulating Tumor DNA in Late Stage Non-Small Cell Lung Cancer Patients by Hao Peng, Lan Lŭ, Zisong Zhou, Jian Liu, Dadong Zhang, Kejun Nan, Xiaochen Zhao, Fugen Li, Lei Tian, Dong Hua, Yu Yao

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment‐resistant bipolar depression

    Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment‐resistant bipolar depression by Xiaochen Zhao, Swarajya Lakshmi Vattem Venkata, Ruin Moaddel, Dave Luckenbaugh, Nancy E. Brutsché, Lobna Ibrahim, Carlos A. Zarate, Donald E. Mager, Irving W. Wainer

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Assessment of nivolumab exposure and clinical safety of 480 mg every 4 weeks flat-dosing schedule in patients with cancer

    Assessment of nivolumab exposure and clinical safety of 480 mg every 4 weeks flat-dosing schedule in patients with cancer by Georgina V. Long, Scott S. Tykodi, Jeffrey Schneider, Claus Garbe, Gwénaëlle Gravis, Michelle Rashford, Sachin Agrawal, E. Grigoryeva, Akintunde Bello, A. Roy, Laétitia Rollin, Xiaochen Zhao

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Model-based evaluation of the efficacy and safety of nivolumab once every 4 weeks across multiple tumor types

    Model-based evaluation of the efficacy and safety of nivolumab once every 4 weeks across multiple tumor types by Xiaochen Zhao, Jun Shen, Vijay Ivaturi, Mathangi Gopalakrishnan, Yufei Feng, Brian J. Schmidt, Paul Statkevich, Vicki Goodman, Jogarao Gobburu, Akintunde Bello, A. Roy, Sachin Agrawal

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway

    PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway by Jiangang Zhou, J. Wu, Bingjie Li, Dongdong Liu, Jing Yu, Xiaomei Yan, Shigang Zheng, Jiguang Wang, Luo Zhang, Luo Zhang, Fuhong He, He Li, Aimin Chen, Yu Zhang, Xiaochen Zhao, Yinghui Guan, Xiaochen Zhao, Yan Jin, Jinxia Ni, Marcelo A. Nóbrega, Bob Löwenberg, Ruud Delwel, Peter J.M. Valk, Ashish Kumar, Lu Xie, Daniel G. Tenen, Gang Huang, Q-f Wang

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Association between DNA damage repair gene somatic mutations and immune‐related gene expression in ovarian cancer

    Association between DNA damage repair gene somatic mutations and immune‐related gene expression in ovarian cancer by Wenjuan Tian, Boer Shan, Yuzi Zhang, Yu Ren, Shanhui Liang, Jing Zhao, Zhengyi Zhao, Guoqiang Wang, Xiaochen Zhao, Dongxian Peng, Rui Bi, Shangli Cai, Yuezong Bai, Huaying Wang

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Assessment of nivolumab benefit–risk profile of a 240-mg flat dose relative to a 3-mg/kg dosing regimen in patients with advanced tumors

    Assessment of nivolumab benefit–risk profile of a 240-mg flat dose relative to a 3-mg/kg dosing regimen in patients with advanced tumors by Xiaochen Zhao, Satyendra Suryawanshi, Matthew Hruska, Yufei Feng, X. Wang, Jun Shen, Heather Vezina, M. Brent McHenry, Ian M. Waxman, A. Achanta, Akintunde Bello, Amit Roy, Sachin Agrawal

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Circulating tumor DNA predicts neoadjuvant immunotherapy efficacy and recurrence-free survival in surgical non-small cell lung cancer patients

    Circulating tumor DNA predicts neoadjuvant immunotherapy efficacy and recurrence-free survival in surgical non-small cell lung cancer patients by Dongsheng Yue, Weiran Liu, Chen Chen, Tao Zhang, Yuchen Ma, Longgang Cui, Yajun Gu, Ting Bei, Xiaochen Zhao, Bei Zhang, Yuezong Bai, Atocha Romero, Meng Xu‐Welliver, Changli Wang, Zhenfa Zhang, Bin Zhang

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Mutations of PI3K-AKT-mTOR pathway as predictors for immune cell infiltration and immunotherapy efficacy in dMMR/MSI-H gastric adenocarcinoma

    Mutations of PI3K-AKT-mTOR pathway as predictors for immune cell infiltration and immunotherapy efficacy in dMMR/MSI-H gastric adenocarcinoma by Zhenghang Wang, Xinyu Wang, Yu Xu, Jian Li, Xiaotian Zhang, Zhi Peng, Yajie Hu, Xinya Zhao, Kun Dong, Bei Zhang, Chan Gao, Xiaochen Zhao, Hui Chen, Jinping Cai, Yuezong Bai, Yu Sun, Lin Shen

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer

    Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer by Zhenghang Wang, Qi Zhang, Changsong Qi, Yuezong Bai, Feilong Zhao, Hui Chen, Zhongwu Li, Xicheng Wang, Mifen Chen, Jifang Gong, Zhi Peng, Xiaotian Zhang, Jinping Cai, Shiqing Chen, Xiaochen Zhao, Lin Shen, Jian Li

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer

    Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer by Danyang Sun, Junxun Ma, Jinliang Wang, Chun Han, Yuanyu Qian, Guang‐Ying Chen, Xiaoyan Li, Juan Zhang, Pengfei Cui, Wushuang Du, Zhaozhen Wu, Shixue Chen, Xuan Zheng, Zhichao Yue, Jia Song, Chan Gao, Xiaochen Zhao, Shangli Cai, Yi Hu

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer

    Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer by Jianchun Duan, Longgang Cui, Xiaochen Zhao, Hua Bai, Shangli Cai, Guoqiang Wang, Zhengyi Zhao, Jing Zhao, Shiqing Chen, Jia Song, Chuang Qi, Qīng Wáng, Mengli Huang, Yuzi Zhang, Depei Huang, Yuezong Bai, Feng Sun, J. Jack Lee, Zhijie Wang, Jie Wang

    Published 2019
    Get full text
    Revisão
    Save to List
    Saved in:
  19. 19
    Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade

    Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade by Zhijie Wang, Jing Zhao, Guoqiang Wang, Fan Zhang, Zemin Zhang, Fan Zhang, Yuzi Zhang, Dong Hua, Xiaochen Zhao, Jianchun Duan, Hua Bai, Yanhua Tian, Rui Wan, Miao Han, Yan Cao, Lei Xiong, Li Liu, Shuhang Wang, Shangli Cai, Tony Mok, Jie Wang

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Identification of Deleterious<i>NOTCH</i>Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC

    Identification of Deleterious<i>NOTCH</i>Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC by Kai Zhang, Xiaohua Hong, Zhengbo Song, Yu Xu, Chengcheng Li, Guoqiang Wang, Yuzi Zhang, Xiaochen Zhao, Zhengyi Zhao, Jing Zhao, Mengli Huang, Depei Huang, Chuang Qi, Chan Gao, Shangli Cai, Feifei Gu, Yue Hu, Chunwei Xu, Wenxian Wang, Zhenkun Lou, Yong Zhang, Li Liu

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: